Table 1. Snapshot of Europe Pharmacogenomics Market, 2019-2030 19
Table 2. Web-based Resources of Pharmacogenomics 24
Table 3. Main Product Trends and Market Opportunities in Europe Pharmacogenomics Market 34
Table 4. Europe Pharmacogenomics Market by Service, 2019-2030, $ mn 42
Table 5. Medicine/Gene Matching in Pharmacogenetic Testing 47
Table 6. Europe Pharmacogenomics Market by Technology, 2019-2030, $ mn 49
Table 7. Europe Pharmacogenomics Market by Application, 2019-2030, $ mn 57
Table 8. Important Drug-Gene Pairs Relevant to Neurology and Psychiatry 62
Table 9. Europe Pharmacogenomics Market by End User, 2019-2030, $ mn 66
Table 10. Europe Pharmacogenomics Market by Country, 2019-2030, $ mn 73
Table 11. Germany Pharmacogenomics Market by Service, 2019-2030, $ mn 75
Table 12. Germany Pharmacogenomics Market by Technology, 2019-2030, $ mn 75
Table 13. Germany Pharmacogenomics Market by Application, 2019-2030, $ mn 75
Table 14. UK Pharmacogenomics Market by Service, 2019-2030, $ mn 78
Table 15. UK Pharmacogenomics Market by Technology, 2019-2030, $ mn 78
Table 16. UK Pharmacogenomics Market by Application, 2019-2030, $ mn 78
Table 17. France Pharmacogenomics Market by Service, 2019-2030, $ mn 80
Table 18. France Pharmacogenomics Market by Technology, 2019-2030, $ mn 80
Table 19. France Pharmacogenomics Market by Application, 2019-2030, $ mn 80
Table 20. Spain Pharmacogenomics Market by Service, 2019-2030, $ mn 82
Table 21. Spain Pharmacogenomics Market by Technology, 2019-2030, $ mn 82
Table 22. Spain Pharmacogenomics Market by Application, 2019-2030, $ mn 82
Table 23. Italy Pharmacogenomics Market by Service, 2019-2030, $ mn 84
Table 24. Italy Pharmacogenomics Market by Technology, 2019-2030, $ mn 84
Table 25. Italy Pharmacogenomics Market by Application, 2019-2030, $ mn 84
Table 26. Russia Pharmacogenomics Market by Service, 2019-2030, $ mn 86
Table 27. Russia Pharmacogenomics Market by Technology, 2019-2030, $ mn 86
Table 28. Russia Pharmacogenomics Market by Application, 2019-2030, $ mn 86
Table 29. Pharmacogenomics Market in Rest of Europe by Country, 2019-2030, $ mn 88
Table 30. Product Approvals by Company, January 2016 April 2019 91
Table 31. Breakdown of Europe Market by Key Vendor, 2019, % 91
Table 32. 23andMe, Inc.: Company Snapshot 94
Table 33. 23andMe, Inc.: Business Segmentation 94
Table 34. 23andMe, Inc.: Product Portfolio 95
Table 35. 23andMe, Inc.: Revenue, 2016-2018, $ mn 95
Table 36. 23andMe, Inc.: Recent Developments 95
Table 37. Risk Evaluation for Investing in Europe Market, 2019-2030 120
Table 38. Critical Success Factors and Key Takeaways 123

LIST OF FIGURE

Figure 1. Research Method Flow Chart 12
Figure 2. Breakdown of Primary Research 14
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18
Figure 5. Europe Pharmacogenomics Market, 2019-2030, $ mn 21
Figure 6. An Overall Process of How Pharmacogenomics Functions in a Clinical Practice 23
Figure 7. Impact of COVID-19 on Business 25
Figure 8. Primary Drivers and Impact Factors of Europe Pharmacogenomics Market 27
Figure 9. World Top 10 Causes of Deaths, 2016 30
Figure 10. Primary Restraints and Impact Factors of Europe Pharmacogenomics Market 31
Figure 11. Consecutive Phases and Associated Challenges in Pharmacogenomics 33
Figure 12. Investment Opportunity Analysis 35
Figure 13. Porters Fiver Forces Analysis of Europe Pharmacogenomics Market 38
Figure 14. Breakdown of Europe Pharmacogenomics Market by Service, 2019-2030, % of Revenue 42
Figure 15. Europe Addressable Market Cap in 2020-2030 by Service, Value ($ mn) and Share (%) 43
Figure 16. Europe Pharmacogenomics Market: Genotyping, 2019-2030, $ mn 44
Figure 17. Europe Pharmacogenomics Market: SNP Identification, 2019-2030, $ mn 45
Figure 18. Europe Pharmacogenomics Market: Diagnostics, 2019-2030, $ mn 46
Figure 19. Europe Pharmacogenomics Market: Other Services, 2019-2030, $ mn 48
Figure 20. Breakdown of Europe Pharmacogenomics Market by Technology, 2019-2030, % of Sales Revenue 49
Figure 21. Europe Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 50
Figure 22. Europe Pharmacogenomics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 51
Figure 23. Europe Pharmacogenomics Market: Microarray, 2019-2030, $ mn 52
Figure 24. Europe Pharmacogenomics Market: Sequencing, 2019-2030, $ mn 53
Figure 25. Europe Pharmacogenomics Market: Electrophoresis, 2019-2030, $ mn 54
Figure 26. Europe Pharmacogenomics Market: Mass Spectrometry, 2019-2030, $ mn 55
Figure 27. Europe Pharmacogenomics Market: Other Technologies, 2019-2030, $ mn 56
Figure 28. Breakdown of Europe Pharmacogenomics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 29. Europe Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 30. Europe Pharmacogenomics Market: Oncology, 2019-2030, $ mn 59
Figure 31. Europe Pharmacogenomics Market: Infectious Diseases, 2019-2030, $ mn 60
Figure 32. Europe Pharmacogenomics Market: Neurology/Psychiatry, 2019-2030, $ mn 61
Figure 33. Europe Pharmacogenomics Market: Cardiovascular, 2019-2030, $ mn 63
Figure 34. Europe Pharmacogenomics Market: Pain Management, 2019-2030, $ mn 64
Figure 35. Europe Pharmacogenomics Market: Other Applications, 2019-2030, $ mn 65
Figure 36. Breakdown of Europe Pharmacogenomics Market by End User, 2019-2030, % of Revenue 66
Figure 37. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 67
Figure 38. Europe Pharmacogenomics Market: Hospitals and Clinics, 2019-2030, $ mn 68
Figure 39. Europe Pharmacogenomics Market: Pharmaceutical Companies, 2019-2030, $ mn 69
Figure 40. Europe Pharmacogenomics Market: Research Institutes, 2019-2030, $ mn 70
Figure 41. Breakdown of European Pharmacogenomics Market by Country, 2019 and 2030, % of Revenue 72
Figure 42. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 73
Figure 43. Pharmacogenomics Market in Germany, 2019-2030, $ mn 74
Figure 44. Pharmacogenomics Market in UK, 2019-2030, $ mn 76
Figure 45. Pharmacogenomics Market in France, 2019-2030, $ mn 79
Figure 46. Pharmacogenomics Market in Spain, 2019-2030, $ mn 81
Figure 47. Pharmacogenomics Market in Italy, 2019-2030, $ mn 83
Figure 48. Pharmacogenomics Market in Russia, 2019-2030, $ mn 85
Figure 49. Pharmacogenomics Market in Rest of Europe, 2019-2030, $ mn 87
Figure 50. Growth Stage of Europe Pharmacogenomics Industry over the Forecast Period 89